Yee Ying Leung
Director Ejecutivo en Antiviral Technologies, Inc. .
Perfil
Yee Ying Leung is the founder of Walcom Group Ltd.
Currently, Ms. Leung is the Chief Executive Officer & Director at Antiviral Technologies, Inc. Ms. Leung completed an undergraduate degree from the University of Toronto in 1985.
Cargos activos de Yee Ying Leung
Empresas | Cargo | Inicio |
---|---|---|
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Director Ejecutivo | 28/03/2014 |
Antiguos cargos conocidos de Yee Ying Leung.
Empresas | Cargo | Fin |
---|---|---|
WALCOM GROUP LIMITED | Fundador | - |
Formación de Yee Ying Leung.
University of Toronto | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Finance |
Walcom Group Ltd.
Walcom Group Ltd. Pharmaceuticals: GenericHealth Technology Walcom Group Ltd. is a holding company, which engages in the research, development, commercialization, production and marketing of animal feed additive products. Its products include Porcinin Plus, Porcimax, Eggronin Plus, and Aquanin Plus. It operates through the following geographical segments: Hong Kong, China, Philippines, Thailand, Taiwan, Other Asia-Pacific Countries, Europe and the United Kingdom, America and Canada, and Others. The company was founded in 2004 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Yee Ying Leung